Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cesamet for chemotherapy-induced neuropathic pain
NCT00380965Phase 4Completed
- Sponsor
- NEMA Research
- Start
- Oct 2006
- Primary completion
- Oct 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of nabilone in chemotherapy-induced peripheral neuropathy (CIPN), sponsored by NEMA Research. Started Oct 2006; status: completed.
02
Drugs
nabilone
03
Conditions
chemotherapy-induced peripheral neuropathy (CIPN)
Beyond the preview
Go deeper on NCT00380965.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00380965.